MRNA

Moderna
D

MRNA

24.190
USD
0.11
(0.46%)
قبل الجلسة
حجم التداول
379
الربح لكل سهم
-11
العائد الربحي
-
P/E
-3
حجم السوق
9,411,839,322
التوصيات
Abdilatif
Abdilatif
منذ 4 أشهر
buy
MRNA
MRNA @26.15
2025-04-14 06:32
MRNA@26.15 Chart
الربح
-294.00
-7.50%
Abdilatif
Abdilatif
منذ سنة
sell
MRNA
MRNA @101.02
2024-02-01 03:45
MRNA@101.02 Chart
الربح
11,524.50
76.05%
Abdilatif
Abdilatif
منذ سنة
sell
MRNA
MRNA @101.83
2024-01-29 04:09
MRNA@101.83 Chart
الربح
11,646.00
76.24%
المزيد
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ 11 شهر
neutral
2024-10-01 04:30
MRNA Chart
المزيد
أصول ذات صلة
AZN
AZN
0.310
(0.39%)
80.210 USD
BNTX
BNTX
0.605
(0.60%)
100.650 USD
GSK
GSK
-0.710
(-1.79%)
38.955 USD
I
INO
0.20000
(8.44%)
2.57000 USD
JNJ
JNJ
0.865
(0.49%)
178.070 USD
MRK
MRK
1.340
(1.59%)
85.470 USD
N
NVAX
0.08000
(1.07%)
7.56000 USD
PFE
PFE
0.225
(0.91%)
24.980 USD
T
TDOC
-0.09500
(-1.23%)
7.63500 USD
المزيد
الأخبار المقالات

العنوان: Moderna

القطاع: Healthcare
الصناعة: Biotechnology
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.